Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Incyte Corporation (INCY)

2014-10-25@06:23:07 ET
Form 4: Update Filing for Incyte Corp (INCY) (VKR)

2014-10-23@13:33:50 ET
Shares of Incyte Receive a Boost, Up 4.0% (F77)

2014-10-23@11:32:01 ET
Global B-Cell Non-Hodgkin Lymphoma Therapeutics Pipeline Review H2 2014 - 43 Drug Profiles from 28 Leading Pharma Companies (MTO)

2014-10-23@08:00:06 ET
Incyte to Present at the Nomura BioPharma Conference (BIZ)

2014-10-22@04:57:25 ET
Form 144: Filing to Sell 8000 Shares of Incyte Corp (INCY) (VKR)

2014-10-21@05:18:57 ET
Form 4: Update Filing for Incyte Corp (INCY) (VKR)

2014-10-20@11:05:17 ET
Incyte appoints executive vice president and CFO (DTM)

2014-10-18@21:02:33 ET
Incyte CorporationCorporate Event Announcement Notice (WSH)

2014-10-17@21:23:04 ET
Incyte CorporationCorporate Event Announcement Notice (WSH)

2014-10-17@08:11:51 ET
Best Relative Performance in the Biotechnology Industry Detected in Shares of Vanda Pharmaceuticals (VNDA, THRX, INCY, PDLI, NPSP) (F70)

2014-10-17@08:00:29 ET
Incyte Appoints David Gryska as Executive Vice President and Chief Financial Officer (BIZ)

2014-10-16@21:29:36 ET
Incyte CorporationCorporate Event Announcement Notice (WSH)

2014-10-16@13:24:10 ET
Buyers Accumulate Shares of Incyte, Up 3.6% (F77)

2014-10-15@21:27:21 ET
Incyte CorporationCorporate Event Announcement Notice (WSH)

2014-10-15@12:12:21 ET
Incyte Bullish Moving Average Crossover Alert (INCY) (F78)